Dupixent lawsuits allege that the drug’s manufacturers failed to warn asthma patients and others about the prescription drug’s link to the rare but aggressive form of skin cancer, cutaneous T-cell lymphoma (CTCL). Patients who developed CTCL after using this injectable medication are encouraged to speak with an attorney about their legal rights...